Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 187

1.

A study of the planarity of the pyrrolone fragment in 2-isopropyl-2,3-dihydro-1H-isoindol-1-one.

Donkeng Dazie J, Liška A, Ludvík J, Fábry J, Dušek M.

Acta Crystallogr C Struct Chem. 2016 Jul 1;72(Pt 7):518-24. doi: 10.1107/S2053229616008767. Epub 2016 Jun 3.

PMID:
27377271
2.

A redetermination from the original data of the crystal structure of 2-amino-4,6-di-meth-oxy-pyrimidin-1-ium 4-amino-benzoate.

Fábry J.

Acta Crystallogr E Crystallogr Commun. 2016 Mar 18;72(Pt 4):512-5. doi: 10.1107/S2056989016004321. eCollection 2016 Apr 1.

3.

Redetermination of cytosinium hydrogen maleate-cytosine (1/1) from the original data.

Fábry J.

Acta Crystallogr E Crystallogr Commun. 2016 Mar 15;72(Pt 4):509-11. doi: 10.1107/S2056989016003923. eCollection 2016 Apr 1.

4.

Structure determination of KScS₂, RbScS₂ and KLnS₂ (Ln = Nd, Sm, Tb, Dy, Ho, Er, Tm and Yb) and crystal-chemical discussion.

Havlák L, Fábry J, Henriques M, Dušek M.

Acta Crystallogr C Struct Chem. 2015 Jul;71(Pt 7):623-30. doi: 10.1107/S2053229615011833. Epub 2015 Jun 27.

PMID:
26146403
5.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group.

N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. Erratum in: N Engl J Med. 2015 Aug 6;373(6):586.

6.

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).

Bolli GB, Riddle MC, Bergenstal RM, Ziemen M, Sestakauskas K, Goyeau H, Home PD; on behalf of the EDITION 3 study investigators.

Diabetes Obes Metab. 2015 Apr;17(4):386-94. doi: 10.1111/dom.12438. Epub 2015 Feb 12.

7.

Training infection control and hospital hygiene professionals in Europe, 2010: agreed core competencies among 33 European countries.

Brusaferro S, Cookson B, Kalenic S, Cooper T, Fabry J, Gallagher R, Hartemann P, Mannerquist K, Popp W, Privitera G, Ruef C, Viale P, Coiz F, Fabbro E, Suetens C, Varela Santos C; National representatives of the Training in Infection Control in Europe (TRICE) project.

Euro Surveill. 2014 Dec 11;19(49). pii: 20985.

8.

High- and low-temperature phases in isostructural 4-chloro-3-nitroaniline and 4-iodo-3-nitroaniline.

Fábry J, Dušek M, Vaněk P, Rafalovskyi I, Hlinka J, Urban J.

Acta Crystallogr C Struct Chem. 2014 Dec;70(Pt 12):1153-60. doi: 10.1107/S2053229614024632. Epub 2014 Nov 19.

PMID:
25471417
9.

Comparison of the hydrogen-bond patterns in 2-amino-1,3,4-thiadiazolium hydrogen oxalate, 2-amino-1,3,4-thiadiazole-succinic acid (1/2), 2-amino-1,3,4-thiadiazole-glutaric acid (1/1) and 2-amino-1,3,4-thiadiazole-adipic acid (1/1).

Matulková I, Císařová I, Němec I, Fábry J.

Acta Crystallogr C Struct Chem. 2014 Oct;70(Pt 10):927-33. doi: 10.1107/S2053229614018269. Epub 2014 Sep 4.

PMID:
25279589
10.

Redetermination of NaGdS2, NaLuS2 and NaYS2.

Fábry J, Havlák L, Kučeráková M, Dušek M.

Acta Crystallogr C Struct Chem. 2014 Jun;70(Pt 6):533-5. doi: 10.1107/S2053229614009607. Epub 2014 May 6.

PMID:
24898952
11.

Structure determination of KLaS2, KPrS2, KEuS2, KGdS2, KLuS2, KYS2, RbYS2, NaLaS2 and crystal-chemical analysis of the group 1 and thallium(I) rare-earth sulfide series.

Fábry J, Havlák L, Dušek M, Vaněk P, Drahokoupil J, Jurek K.

Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Apr;70(Pt 2):360-71. doi: 10.1107/S2052520613034574. Epub 2014 Mar 28.

PMID:
24675605
12.

Development and assessment of national performance indicators for infection prevention and control and antimicrobial stewardship in European long-term care facilities.

Cookson B, Mackenzie D, Kafatos G, Jans B, Latour K, Moro ML, Ricchizzi E, Van de Mortel M, Suetens C, Fabry J; National Network Representatives for the Healthcare-Associated Infections in Long-Term Care Facilities (HALT) Project.

J Hosp Infect. 2013 Sep;85(1):45-53. doi: 10.1016/j.jhin.2013.04.019. Epub 2013 Aug 6.

PMID:
23932737
13.

Effect of chromium-enriched yeast on fasting plasma glucose, glycated haemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin.

Racek J, Sindberg CD, Moesgaard S, Mainz J, Fabry J, Müller L, Rácová K.

Biol Trace Elem Res. 2013 Oct;155(1):1-4. doi: 10.1007/s12011-013-9758-9. Epub 2013 Aug 7.

PMID:
23921483
14.

Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.

Wilding JP, Woo V, Rohwedder K, Sugg J, Parikh S; Dapagliflozin 006 Study Group.

Diabetes Obes Metab. 2014 Feb;16(2):124-36. doi: 10.1111/dom.12187. Epub 2013 Aug 29.

PMID:
23911013
15.

Consumption of psychoactive substances among 535 women entering a Lyon prison (France) between June 2004 and December 2008.

Sahajian F, Lamothe P, Fabry J, Vanhems P.

Rev Epidemiol Sante Publique. 2012 Oct;60(5):371-81. doi: 10.1016/j.respe.2012.02.010. Epub 2012 Sep 13.

PMID:
22981309
16.

[Alliance against MDRO: safeguarding antibiotics].

Carlet J, Rambaud C, Pulcini C; l'Alliance contre développement des bactéries multirésistantes (ACdeBMR).

Ann Fr Anesth Reanim. 2012 Sep;31(9):704-8. doi: 10.1016/j.annfar.2012.07.003. Epub 2012 Aug 24. French.

PMID:
22925945
17.

Deep nasal inspirations increase the cough threshold in children with mild asthma.

Pecova R, Michnova T, Fabry J, Zatko T, Neuschlova M, Klco P, Hanacek J, Tatar M, Tomori Z.

Adv Exp Med Biol. 2013;755:65-9.

PMID:
22826050
18.

N-[Amino(imino)methyl]uronium tetrafluoroborate.

Fridrichová M, Fábry J, Fejfarová K, Krupková R, Vaněk P.

Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1114-5. doi: 10.1107/S1600536812010665. Epub 2012 Mar 17.

19.

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

Garber AJ, King AB, Del Prato S, Sreenan S, Balci MK, Muñoz-Torres M, Rosenstock J, Endahl LA, Francisco AM, Hollander P; NN1250-3582 (BEGIN BB T2D) Trial Investigators.

Lancet. 2012 Apr 21;379(9825):1498-507. doi: 10.1016/S0140-6736(12)60205-0.

PMID:
22521072
20.

Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.

Wilding JP, Woo V, Soler NG, Pahor A, Sugg J, Rohwedder K, Parikh S; Dapagliflozin 006 Study Group.

Ann Intern Med. 2012 Mar 20;156(6):405-15. doi: 10.7326/0003-4819-156-6-201203200-00003.

PMID:
22431673

Supplemental Content

Loading ...
Support Center